EichorEICHOR
Location: Roswell Synced from ClinicalTrials.gov · August 09, 2026

Clinical studies recruiting near Roswell

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

A Study of JNJ-86974680 in Participants With Advanced Non-small Cell Lung Cancer
Phase 1 · Johnson & Johnson Enterprise Innovation Inc. · NCT06116786A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patie
NA · Roswell Park Cancer Institute · NCT06896695Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296ABL001 + Dasatinib + Prednisone + Blinatumomab in BCR-ABL+ B-ALL or CML
Phase 1 · Marlise Luskin, MD · NCT03595917Proton or Photon RT for Retroperitoneal Sarcomas
Phase 1/Phase 2 · Massachusetts General Hospital · NCT01659203Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy Subjects
NA · Roswell Park Cancer Institute · NCT03897270Fluorescence Image Guided Surgery Followed by Intraoperative Photodynamic Therapy for Improving Local Tumor Control in P
Phase 1/Phase 2 · Roswell Park Cancer Institute · NCT06307548A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478Testing the Addition of a New Anti-cancer Drug, M3814 (Peposertib), to the Usual Radiotherapy in Patients With Locally A
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT04172532GB-5267 for the Treatment Platinum-Resistant Ovarian, Peritoneal, or Fallopian Tube Cancer
Phase 1 · Roswell Park Cancer Institute · NCT07489287MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
Phase N/A · Agendia · NCT03053193Low-Intensity Mechanical Stimulation for Hematologic Malignancy Patients
NA · Roswell Park Cancer Institute · NCT05893940A Study of Combination Chemotherapy for Patients With Newly Diagnosed DAWT and Relapsed FHWT
Phase 2 · Children's Oncology Group · NCT04322318Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM
Phase 2 · SWOG Cancer Research Network · NCT06769126Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma
Phase 2 · Roswell Park Cancer Institute · NCT04682158Temozolomide and Survivin Long Peptide Vaccine (SurVaxM) for the Treatment of Patients With Progressing Metastatic Neuro
Phase 2 · Roswell Park Cancer Institute · NCT06202066Behavioral Parenting Skills as a Novel Target for Improving Pediatric Medication Adherence: Study 3
NA · Roswell Park Cancer Institute · NCT06074666Study of SGR-1505 in Mature B-Cell Neoplasms
Phase 1 · Schrödinger, Inc. · NCT05544019Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastati
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06931340Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120)
Phase 2 · Icahn School of Medicine at Mount Sinai · NCT05835466SX-682 in Combination With Carfilzomib, Daratumumab-Hyaluronidase, and Dexamethasone in Patients With Relapsed or Refrac
Phase 1 · Roswell Park Cancer Institute · NCT06622005A Study of Vedolizumab With Tofacitinib in Adults With Ulcerative Colitis (UC)
Phase 4 · Gastroenterology Consultants, P.C. · Takeda · NCT06095128A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung C
Phase 3 · Merck Sharp & Dohme LLC · NCT06623422Carcinogen and Toxicant Exposure Among Young Adults Who Co-Use E-cigarettes and Cannabis (Co-Tox Study)
Phase N/A · Roswell Park Cancer Institute · NCT07167225A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax,
Phase 1 · Kura Oncology, Inc. · NCT05735184ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol
Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714Understanding Tobacco and Cannabis Co-Use Practices: Initiation, Escalation, and Maintenance
Phase N/A · Roswell Park Cancer Institute · NCT07439471
Look up another city
Look up another condition
Eichor
Clinical intelligence from public evidence
Use of Eichor is governed by our Terms of Use · Privacy Policy
© 2026 Biomedistats LLC (dba Eichor)

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.